Biotech Week articles from December 2004

Biotech Week archives from December 2004

Trial aims for safer drug prescribing for institutionalized elderly.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Baycrest Center for Geriatric Care is the first long-term care facility in Canada, and one of the first in North America, to take a major leap forward in the use of health information technology to...

Analysis shows Remicade reduces pain associated with Crohn disease.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Remicade (infliximab), the only biologic approved for the treatment of Crohn disease, was found to reduce pain associated with the disease. According to a new sub-analysis from the ACCENT I (A...

BrainGate Neural Interface translates neural activity into computer control.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Cyberkinetics Neurotechnology Systems, Inc., (CYKN) (Cyberkinetics) announced that additional findings of the BrainGate Neural Interface System pilot clinical study were presented at the annual meeting...

Alimta approved as first U.K.-licensed treatment for mesothelioma.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Lilly U.K. announced that Alimta (pemetrexed) will be available shortly for the treatment of people diagnosed with mesothelioma, a cancer of the lining of the lungs for which there is no known cure. ...

Engineered stem cells can home in on tumors and deliver drug payload in mice.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers at M.D. Anderson Cancer Center in Houston have perfected a delivery system for anticancer treatment that zeroes in on a tumor and becomes part of its supporting tissue. This new...

PuraMatrix launched through partnership with BD Biosciences.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- 3DM, Inc., a Cambridge-based developer of synthetic biomaterial polymers, has announced a worldwide co-branded marketing and distribution partnership with BD Biosciences - Discovery Labware. The...

Milestone achieved in research collaboration with Sanofi-Aventis.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- 4SC AG, a German drug discovery and development company and Sanofi-Aventis, a major pharmaceutical company with its headquarters in Paris, France, announced the successful completion of a research...

Study finds changes in manufacturers' prices of generic drugs vary widely.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- A new AARP study found that manufacturers' prices for some generic drugs experienced a rapid rise over the past 3 years. However, these increases would have added only a few dollars per year to...

Clinical data shows eTag's potential in predicting response to cancer treatment.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- ACLARA BioSciences (ACLA) announced that Sharat Singh, PhD, ACLARA's chief technical officer, presented data from a pilot clinical trial demonstrating the ability of ACLARA's eTag assays to correctly...

U.S. FDA clears second stage of CoFactor phase II trial.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- ADVENTRX Pharmaceuticals, Inc., (ANX) announced that it has been granted allowance by the U.S. Food and Drug Administration (FDA) to begin recruiting patients for the second stage of its phase II trial...

Nutritional supplements company elects new board member.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- AMS Health Sciences, Inc., (AMM) announced that C. Brent Haggard was nominated and has been elected to the company's board of directors by unanimous written consent. Haggard replaces Steven Hague...

Collaboration on novel cancer targets extended.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- ARIU.S. Research, Inc., (ARI) and Oxford BioMedica (OXB) announced the first milestone and their decision to move into the next Phase of their collaboration to discover and characterize novel cancer...

Pharmaceutical firm reports loss of $0.14 per share.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- AVI BioPharma, Inc., (AVII) reported financial results for the 3 and 9 months ended September 30, 2004. For the third quarter of 2004, the company reported a net loss of $5.1 million, or $0.14 per...

Alcohol consumption at time of conception increases risk of pregnancy loss.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Both male and female alcohol intake during the week of conception increases the risk of early pregnancy loss, perinatologists in Denmark report. T.B. Henriksen and colleagues, Aarhus University...

Vasodilating treatment may be superior for repair of microcirculation.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers have compared long-term angiotensin-converting enzyme inhibition and beta-blockade in patients with essential hypertension. Scientists in Denmark report, "Hypertension is associated with...

Regenerative medicines company raises $10M in equity financing.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) announced that it has executed definitive Stock Purchase Agreements for the sale of approximately 8.26 million shares of the company's common stock in a registered...

Agreement signed for automated molecular diagnostics system.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Abbott (ABT) and BioGenex Laboratories announced an agreement to distribute and market a new system that will fully automate molecular diagnostic tests that employ Abbott's proprietary Fluorescence in...

Lopinivir efficacy decreases following cotransfection of wild-type HIV clones.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- The efficacy of lopinivir decreases following cotransfection of wild-type HIV clones. "The impact of cotransfection of mixtures of mutant and wild type (WT) virus on the observed phenotype and...

Cardiac device maker reports 95% revenue growth.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Abiomed, Inc., (ABMD) released financial results for the second quarter of fiscal year 2005 ended September 30, 2004. Highlights include: 1) Total revenues of $10.4 million, the highest quarter...

Pharmaceutical firm reports 30.8% increase in sales.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Able Laboratories, Inc., (ABRX) announced financial results for the 3 months ended September 30, 2004. For the third quarter of 2004, the company reported net sales of $27.3 million, a 30.8%...

Abnormal relapse of atypical hemolytic uremic syndrome described.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- An abnormal relapse of atypical hemolytic uremic syndrome (HUS) has been described in a pediatric kidney transplant recipient. Atypical HUS "frequently leads to end-stage renal failure and can...

Early-onset gastric carcinomas display distinct molecular characteristics.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Early-onset gastric carcinomas display distinct molecular characteristics as compared with gastric carcinomas occurring at a later stage. "Gastric cancer is thought to result from a combination of...

Biotech company reports loss of $0.17 per share.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Accelr8 Technology Corporation (AXK) reported a "loss from continuing operations before income tax benefit" of $1,698,822 for the fiscal year ended July 31, 2004, compared to a "loss from continuing...

Biopharmaceutical firm reaffirms fiscal 2005 estimates.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Accredo Health, Incorporated, (ACDO) reported results for its first quarter ended September 30, 2004. Revenues for the quarter increased 24% to $416,126,000 compared to $334,984,000 for the same...

Positive phase II results reported on Rifalazil.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- ActivBiotics, Inc., announced results from a phase II trial of its investigational antibiotic, rifalazil, in the treatment of acute non-gonococcal urethritis (NGU). The trial met all primary...

Pharmaceutical firm makes two key additions to its senior management team.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Adams Respiratory Therapeutics, a provider of specialty pharmaceuticals for respiratory care, announced the appointment of two new members to its senior management team. Helmut Albrecht, MD has...

Biopharmaceutical company reports loss of $0.22 per share.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Adolor Corporation (ADLR) reported financial results for the 3 and 9 months ended September 30, 2004. For the 3 months ended September 30, 2004, the company reported a net loss of $8.7 million or...

Fourth installment of funding received by AIDS drug maker.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corp. (ADVR) announced that it received the fourth installment of $3 million from James Dicke II and his son, James Dicke III. As announced, on February 3, 2004, ADVR entered...

Researchers report on pulsatile dosing of antimicrobials at conference.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Advancis Pharmaceutical Corporation (NASDAQ:AVNC) announced that researchers presented findings regarding the company's pulsatile dosing of antimicrobials during the 44th Annual Interscience Conference...

Paper published on the origin and function of skin-derived precursors.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Aegera Therapeutics Inc. announced the publication of Dr. Freda Miller's second paper on the origin and function of skin-derived precursor (SKPs), a novel source of multipotent adult stem cells, in the...

Preclinical data presented on antibacterial agents.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Affinium Pharmaceuticals, a structure-guided drug discovery and development company, said researchers will present studies of potent antibacterial agents at the 44th annual Interscience Conference on...

ELISA for detection of yessotoxin and its analogs developed.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Scientists have developed an enzyme-linked immunosorbent assay (ELISA) for the detection of yessotoxin and its analogs. "Polyclonal antibodies were produced for the development of competitive...

Optimal interval duration for eliciting a high physiological load is 3-5 minutes.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers have investigated the effect of work duration on physiological and rating scale of perceived exertion responses during self-paced interval training. According to research from Norway,...

Acquisition of life science informatics company completed.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Agilent Technologies, Inc., (A) announced the completion of its acquisition of Silicon Genetics, a provider of software solutions for life science discovery. Agilent and Silicon Genetics had...

Orthopedic device firm acquired by Tailwind Capital.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Aircast Incorporated announced that it will be acquired by Tailwind Capital Partners, a private equity investment firm focused on healthcare and other growth sectors of the economy. Aircast's board...

Hemodialysis systems maker reports loss of $0.21 per share.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Aksys, Ltd., (AKSY) reported results for the third quarter ended September 30, 2004. For the third fiscal quarter of 2004, Aksys reported revenues of $581,000 compared to revenues of $411,000 for...

Non-opioid analgesic improgan exclusively activates brain stem nuclei.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Improgan exclusively activates brain stem nuclei in rats. "Improgan is a compound developed from histamine antagonists which shows the pre-clinical profile of a highly effective, non-opioid...

Drug discovery firm promotes two key technical leaders.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Albany Molecular Research, Inc., (AMRI) announced the promotions of two key personnel. David A. Hunt, PhD, has been promoted to director, analytical quality services. In his new position, Hunt will...

Long MLC kinase differentially phosphorylated in interphase and mitosis.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- The long myosin light chain kinase (MLCK) is differentially phosphorylated in interphase and mitosis. Researchers in New York previously found that MLCK activity "is cell cycle-regulated with a...

Minocycline inhibits HIV-1 infection in microglia.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Minocycline, a tetracycline, inhibits HIV-1 infection in microglia. According to scientists writing in the Journal of Neurovirology, "Human immunodeficiency virus type 1 (HIV-1) infection of the...

Applications of Clostridium and Bacillus proteins reviewed.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Scientists review the biochemistry, biology, and applications of common Clostridium and Bacillus proteins in a recent issue of Microbiology and Molecular Biology Reviews. According to a study from...

Flexible packaging helps Novartis introduce doctors' sample packaging.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Alcoa Flexible Packaging, a leading pharmaceutical packaging supplier, announced that it has introduced shrink sleeve label technology for Novartis' line of Starlix nateglinide Type 2 diabetes...

Treatment initiated in phase III Eculizumab study.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Alexion Pharmaceuticals, Inc., (ALXN) announced that it has initiated the treatment phase in the pivotal phase III TRIUMPH trial, evaluating the investigational drug eculizumab in patients with the...

Vaccination against typhoid fever in travelers is not cost-effective.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Vaccination against typhoid fever in all travelers is not cost-effective. According to a study from Greece, "Analysis of data on the incidence of typhoid fever and the costs of vaccination of...

Pharmaceutical company reports loss of $0.16 per share.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Alkermes, Inc., (ALKS) reported its financial results for the quarter ended September 30, 2004. The net loss on a GAAP basis for the quarter ended September 30, 2004, was $14.3 million or $0.16 per...

Pharmaceutical company reports pharmaceutical sales increased 15%.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Allergan, Inc., (AGN) announced operating results for the third quarter ended September 24, 2004. Allergan also announced that its board of directors has declared a third quarter dividend of $0.09...

Imaging company reports 3.9% increase in revenue.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Alliance Imaging, Inc., (AIQ) announced results for the third quarter and first 9 months ended Sept. 30, 2004. Revenue increased 3.9% to $109.8 million for the third quarter ended Sept. 30, 2004,...

Grant Ventures announces collaboration with Cleveland Clinic subsidiary.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Grant Life Sciences, Inc., (GRTV) announced an agreement with Allogen Laboratories, a wholly owned subsidiary of the Cleveland Clinic Foundation, wherein Allogen will perform testing and validation...

Survival benefit confirmed in patients with brain metastases from breast cancer.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc. (ALTH) announced the presentation of updated results from its phase 3 clinical trial of the investigational radiation sensitizer Efaproxyn (efaproxiral) in patients with brain...

Steroid and lipid conjugates of short interfering RNA improve liver cell uptake.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Steroid and lipid conjugates of short interfering RNA improve liver cell uptake. "Double-stranded short interfering RNAs (siRNAs) mediate post-transcriptional inhibition of gene expression in a...

RNA interference used to cut cholesterol in mouse cells.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- A technique called "RNA interference" (RNAi) holds tremendous promise as a means to cure ailments by shutting off disease-causing genes; however, it has been difficult to make the technique work in the...

Generic pharmaceutical firm reports loss of $0.09 per share.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Alpharma, Inc., (ALO) announced a diluted loss per share of $0.09 for the third quarter of 2004. These results include previously announced charges of $0.07 diluted earnings per share (DEPS)...

Amputations due to diabetes can be prevented.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Taking a minute or two every day to inspect your feet and observing a few simple rules can make the difference in sparing diabetes patients from a preventable outcome of the disease - a foot amputation....

Oral and maxillofacial surgeons increasingly placing dental implants.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- With memories of grandma's dentures resting in a glass of water still fresh in their minds, today's baby boomers are increasingly requesting dental implants to replace their missing teeth. Almost...

Californians lose millions in workers' compensation benefits.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- A new study completed by the Occupational Therapy Association of California (OTAC), and the American Occupational Therapy Association (AOTA), estimates that workers who were injured on the job and...

Chinese biotech firm acquires Heilongjiang Songhuajiang Pharmaceutical.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- American Oriental Bioengineering, Inc., (AOBO) announced the successful integration of formerly state-owned Heilongjiang Songhuajiang Pharmaceutical (HSPL) into AOBO's market-driven operations and...

Physical therapists applaud new Medicare rule.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Physical therapists congratulated the U.S. Centers for Medicare and Medicaid Services (CMS) for issuing final regulations establishing clear qualifications and training standards for individuals who...

Novation contract signed for asthma monitor.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- American Scientific Resources, Inc., (ASRO) announced Novation, the supply company of VHA, Inc., and the University Health System Consortium (UHC), has initiated a supply agreement for the company's...

Antibiotics use alliance report reveals urgency of drug resistance worldwide.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- A new report released at a meeting of the American Society for Microbiology describes the ominous presence of disease-causing micro-organisms resistant to today's front-line drugs. "Shadow...

Pharmaceutical services firm reports strong cash flow from operations.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- AmerisourceBergen Corporation (ABC) reported results for its fiscal fourth quarter and year ended September 30, 2004. "We are disappointed with our performance for the quarter and the year, as a...

Panitumumab with chemotherapy shows promise as colorectal cancer treatment.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Amgen Inc. (AMGN) and Abgenix (ABGX) announced interim data from part one of an ongoing phase II study suggesting that panitumumab, the first fully human monoclonal antibody that inhibits the epidermal...

Aranesp trial launched to evaluate impact of treating anemia on cardiovascular risks.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Amgen, Inc., (AMGN) has initiated a landmark trial to evaluate the impact of treating anemia on cardiovascular outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes. TREAT...

Cancer research deal signed for development of VEGF-B.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Amrad Corporation Limited (AML) and the Ludwig Institute for Cancer Research (LICR) announced a strengthening of their collaboration for the development of Vascular Endothelial Growth Factor B (VEGF-B)...

Pharmaceutical company reports loss of $0.36 per share.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Amylin Pharmaceuticals, Inc., (AMLN) reported financial results for the third quarter ended September 30, 2004. The company reported a net loss of $34.1 million, or $0.36 per share, for the 3...

Hepatitis C viral load reduction reported in phase IB trial of isatoribine.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Anadys Pharmaceuticals, Inc., (ANDS) reported new data from a recently completed multi-component phase IB clinical trial of isatoribine (ANA245) at the American Association for the Study of Liver...

Biotech company announces formation of clinical advisory board.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Androclus Therapeutics announced the formation of a clinical advisory board for Neurology, which has been assembled to guide the company in the clinical development of therapeutics for autoimmune...

Device company presents new VenaCure procedure kit.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- AngioDynamics, Inc., (ANGO) announced its plans to present the company's new VenaCure laser vein treatment procedure kit at the American College of Phlebology's 18th Annual Congress at Marco Island,...

Pharmaceutical company free to provide exclusive license to Boston Scientific.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Angiotech Pharmaceuticals, Inc., (ANPI, ANP) announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act (HSR) has expired pertaining to the proposed grant of an exclusive...

Pharmaceutical company reports 74% revenue increase.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Anika Therapeutics, Inc., (ANIK) reported that revenue for the third quarter ended September 30, 2004, increased 74% to $6,407,000 from $3,688,000 in the third quarter of 2003. The company posted...

Technology for disposable insulin micro-pumps, micro-needles acquired.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Animas Corporation (PUMP) announced that it has entered into license and development agreements with the Swiss company, Debiotech, SA, for MEMS technology and intellectual property related to...

Nanoparticle and emulsified influenza antigen vaccines developed.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Biodegradable nanoparticles and multiple emulsions containing influenza virus antigen were more effective than traditional vaccines at eliciting an immune response. According to a study from...

Transdermal delivery gel technology compared to testosterone patch.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Antares Pharma, Inc., (AMEX:AIS) said that new phase II data on LibiGel, a gel formulation of testosterone, being developed by BioSante Pharmaceuticals, Inc., (AMEX:BPA) highlighted key advantages of...

Cardiac catheterizations can be performed safely in a mobile laboratory.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers have reported on the safety of performing diagnostic cardiac catheterizations in a mobile catheterization laboratory at primary care hospitals. Scientists writing in the journal...

Imaging company hires three new managers.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Applied Imaging Corp. (AICX) announced three new management additions to the company's wholly-owned Circulating Tumor Cell, Inc., (CTC) subsidiary. CTC's purpose is to develop a reagent based automated...

Biomedical device firm appoints Jack E. Stover as board member.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Arbios Systems, Inc., (ABOS), a biomedical device company engaged in the development of proprietary liver assist technologies useful in the treatment of acute liver failure, announced that Jack E....

Biotech company names Page Bouchard senior VP.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Archemix Corp., the privately held biopharmaceutical company discovering and developing aptamer therapeutics, announced the appointment of Page Bouchard as senior VP of Preclinical Drug Discovery and...

License agreement signed with Alza for pain compound.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Ardent Pharmaceuticals, Inc., announced that it has entered into a Feasibility Study, Option and License Agreement with Alza Corporation for the development of DPI-125, Ardent's lead drug candidate for...

Merger proposed with vitamin maker.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Argan, Inc., (AGAX.OB; AGX) has entered into a Letter of Intent detailing its proposed merger with Vitamin Research Products, Inc. Vitamin Research Products is a vertically integrated company that...

Companies to co-develop domain antibody products to treat respiratory disease.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Domantis, Ltd., and Argenta Discovery, Ltd., a respiratory/inflammation drug development company, have entered into an agreement to co-develop fully human Domain Antibody (dAbs) therapeutics for chronic...

Harry Finch named as senior VP at drug development firm.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Argenta-Discovery, Ltd., the respiratory drug development and contract drug discovery company, has appointed (PhD) Harry Finch, a co-inventor of the asthma therapy "Serevent" with more than 30 years...

Pharmaceutical supply company reports 4% increase in revenue.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Argonaut Technologies, Inc., (AGNT) reported financial results for the third quarter ended September 30, 2004. Net sales were $4.8 million for the quarter, compared to $5.2 million in the third...

Pharmaceutical company appoints Peter J. Nelson to board.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Ariad Pharmaceuticals, Inc., (ARIA) announced the appointment of Peter J. Nelson to its board of directors. From 1997 to 2004, Nelson was senior vice president-operations, chief financial officer,...

Vaccine protects cheetah and black rhinoceros against anthrax.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers have developed a vaccine that protects cheetahs and rhinoceroses against anthrax. According to a study from England, Namibia, and the United States, "Institution of a policy of...

Biopharmaceutical firm reports loss of $0.19 per share.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Array BioPharma, Inc., (ARRY) reported financial results for the first quarter of fiscal 2005. For the first quarter of fiscal 2005, Array reported total revenue of $9.9 million, compared to...